Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Geburtshilfe Frauenheilkd · 2019 · PMC6805199 · PMID 31656321

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients with low ER-β expression, especially in ER-α and/or PgR positive and HER2-negative subtype, showed a trend for higher rates of pCR after chemotherapy, which might indicate a proliferative profile and thus higher susceptibility for chemotherapy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.